Skip to main content

A multidisciplinary approach for the stratification of patients with carotid artery disease

Objective

Carotid artery disease, the primary trigger of ischaemic cerebrovascular events including stroke, causes major morbidity, mortality and healthcare costs worldwide. Still, treatment is based on criteria established in the 90s that do not take into account the molecular evolution we have witnessed since, nor the introduction of new medication, leading to remarkably high unnecessary surgical treatment while missing most patients at risk.
TAXINOMISIS will provide novel disease mechanism-based stratification for carotid artery disease patients to address the needs for stratified and personalised therapeutic interventions in the current era. This will be achieved through (1) the dissection of mechanisms mediating carotid artery disease, and identification of susceptibility and protection factors of plaque erosion and/or rupture using longitudinal cohorts and multi-omics, (2) the definition of distinct disease phenotypes and endotypes, and generation of molecular fingerprints of high versus low-risk states through systems medicine, (3) the development of a multilevel risk prediction model of the symptomatic plaque incorporating new biomarkers and advanced imaging, implemented in a software, to assist patient stratification and clinical decision making, (4) the development of novel pharmacogenomics solutions based on lab-on-a-chip technology to support personalized treatment, (5) the evaluation of the new risk prediction model and lab-on-a-chip device in a prospective observational clinical study, and (6) the assessment of regulatory, cost-effectiveness and ethical issues towards the implementation and commercialization of the programme’s outcomes.
TAXINOMISIS has therefore the potential to rationally change the current state-of-the-art in the stratification of patients with carotid artery disease by reducing unnecessary operations, refining medical treatment and opening up new avenues for therapeutic intervention, while strengthening the European biotechnology sector.

Call for proposal

H2020-SC1-2016-2017

See other projects for this call

Sub call

H2020-SC1-2017-Two-Stage-RTD

Coordinator

PANEPISTIMIO IOANNINON
Net EU contribution
€ 760 314,40
Address
Panepistemioypole Panepistemio Ioanninon
45110 Ioannina
Greece

See on map

Region
Ιωάννινα Ήπειρος Βόρεια Ελλάδα
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00

Participants (16)

UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Netherlands
Net EU contribution
€ 808 685,29
Address
Heidelberglaan 100
3584 CX Utrecht

See on map

Region
West-Nederland Utrecht Utrecht
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN
Germany
Net EU contribution
€ 290 029,04
Address
Ismaninger Strasse 22
81675 Muenchen

See on map

Region
Bayern Oberbayern München, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
FACULTY OF MEDICINE, UNIVERSITY OF BELGRADE
Serbia
Net EU contribution
€ 371 841,54
Address
Dr Subotica, 8
11000 Belgrade

See on map

Region
Србија - север Београдски регион Београдска област
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
INTERUNIVERSITAIR MICRO-ELECTRONICA CENTRUM
Belgium
Net EU contribution
€ 798 962,79
Address
Kapeldreef 75
3001 Leuven

See on map

Region
Vlaams Gewest Prov. Vlaams-Brabant Arr. Leuven
Activity type
Research Organisations
Non-EU contribution
€ 0,00
IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON
Greece
Net EU contribution
€ 549 716,54
Address
Soranou Efesiou 4
115 27 Athina

See on map

Region
Κεντρικός Τομέας Αθηνών Aττική Αττική
Activity type
Research Organisations
Non-EU contribution
€ 0,00
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom
Net EU contribution
€ 303 404,04
Address
Wellington Square University Offices
OX1 2JD Oxford

See on map

Region
South East (England) Berkshire, Buckinghamshire and Oxfordshire Oxfordshire
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
ZORA BIOSCIENCES OY
Finland
Net EU contribution
€ 399 404,04
Address
Tietotie 2 C
02150 Espoo

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Manner-Suomi Helsinki-Uusimaa Helsinki-Uusimaa
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
PIRKANMAA HOSPITAL DISTRICT
Finland
Net EU contribution
€ 395 654,04
Address
Teiskontie 35
33521 Tampere

See on map

Region
Manner-Suomi Länsi-Suomi Pirkanmaa
Activity type
Research Organisations
Non-EU contribution
€ 0,00
STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG
Netherlands
Net EU contribution
€ 183 154,04
Address
Otterstraat 118-124
3500 BN Utrecht

See on map

Region
West-Nederland Utrecht Utrecht
Activity type
Research Organisations
Non-EU contribution
€ 0,00
IRCCS OSPEDALE POLICLINICO SAN MARTINO
Italy
Net EU contribution
€ 191 279,04
Address
Largo Rosanna Benzi 10
16132 Genova

See on map

Region
Nord-Ovest Liguria Genova
Activity type
Research Organisations
Non-EU contribution
€ 0,00
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON
Greece
Net EU contribution
€ 252 091,55
Address
6 Christou Lada Str
10561 Athina

See on map

Region
Κεντρικός Τομέας Αθηνών Aττική Αττική
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA
Spain
Net EU contribution
€ 36 615,29
Address
Carrer Rossello 149
08036 Barcelona

See on map

Region
Este Cataluña Barcelona
Activity type
Research Organisations
Non-EU contribution
€ 0,00
Third-party

Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.

HOSPITAL CLINIC DE BARCELONA
Spain
Net EU contribution
€ 128 163,75
Address
Calle Villarroel 170
08036 Barcelona

See on map

Region
Este Cataluña Barcelona
Activity type
Research Organisations
Non-EU contribution
€ 0,00
ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERING BIOIRC DOO
Serbia
Net EU contribution
€ 318 044,71
Address
Prvoslava Stojanovica Street 6
34000 Kragujevac

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Србија - југ Регион Шумадије и Западне Србије Шумадијска област
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
ENGINEERING - INGEGNERIA INFORMATICA SPA

Participation ended

Italy
Net EU contribution
€ 153 263,36
Address
Piazzale Dell'agricoltura 24
00144 Roma

See on map

Region
Centro (IT) Lazio Roma
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
EUROPAISCHER VEREIN FUR KARDIOVASKULARE UND ENDOVASKULARE CHIRURGIE
Switzerland
Net EU contribution
€ 58 779,04
Address
Dufourstrasse 32
000 Zurich

See on map

Region
Schweiz/Suisse/Svizzera Zürich Zürich
Activity type
Research Organisations
Non-EU contribution
€ 0,00